Report Detail
Global High Potency Active Pharmaceutical Ingredients (APIs) Market Insights, Forecast to 2025
- RnM3541855 |
- 19 June, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
High Potency Active Pharmaceutical Ingredients (APIs) have higher active level targeting sever diseases such as tumour cells, infected cells, damaged organs than regular medicine elements.
Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. Increasing incidence of cancer resulted in increasing R&D pertaining to anticancer drugs which thereby propelling the demand for HPAPIs over the forecast period. In addition, rising usage of HPAPI in gynecology & cosmetics are accounted for the further growth.
The global High Potency Active Pharmaceutical Ingredients (APIs) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the High Potency Active Pharmaceutical Ingredients (APIs) market based on company, product type, end user and key regions.
This report studies the global market size of High Potency Active Pharmaceutical Ingredients (APIs) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of High Potency Active Pharmaceutical Ingredients (APIs) in these regions.
This research report categorizes the global High Potency Active Pharmaceutical Ingredients (APIs) market by top players/brands, region, type and end user. This report also studies the global High Potency Active Pharmaceutical Ingredients (APIs) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lonza
Novartis International AG
BASF AG
Carbogen Amcis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb
Pfizer Inc.
Roche Diagnostics.
Hospira Inc
Boehringer Ingelheim
Covidien Plc
Merck & Co
Bayer AG
Sigma-Aldrich Corporation
Sanofi Aventis.
Market size by Product
Synthetic
Biotech
Market size by End User
Oncology
Hormonal
Glaucoma
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global High Potency Active Pharmaceutical Ingredients (APIs) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of High Potency Active Pharmaceutical Ingredients (APIs) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global High Potency Active Pharmaceutical Ingredients (APIs) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of High Potency Active Pharmaceutical Ingredients (APIs) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of High Potency Active Pharmaceutical Ingredients (APIs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of High Potency Active Pharmaceutical Ingredients (APIs) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 High Potency Active Pharmaceutical Ingredients (APIs) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size Growth Rate by Product
- 1.4.2 Synthetic
- 1.4.3 Biotech
- 1.5 Market by End User
- 1.5.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Hormonal
- 1.5.4 Glaucoma
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size
- 2.1.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue 2014-2025
- 2.1.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales 2014-2025
- 2.2 High Potency Active Pharmaceutical Ingredients (APIs) Growth Rate by Regions
- 2.2.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Regions
- 2.2.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 High Potency Active Pharmaceutical Ingredients (APIs) Sales by Manufacturers
- 3.1.1 High Potency Active Pharmaceutical Ingredients (APIs) Sales by Manufacturers
- 3.1.2 High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Manufacturers
- 3.1.3 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration Ratio (CR5 and HHI)
- 3.2 High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Manufacturers
- 3.2.1 High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Manufacturers (2014-2019)
- 3.2.2 High Potency Active Pharmaceutical Ingredients (APIs) Revenue Share by Manufacturers (2014-2019)
- 3.3 High Potency Active Pharmaceutical Ingredients (APIs) Price by Manufacturers
- 3.4 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturing Base Distribution, Product Types
- 3.4.1 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers High Potency Active Pharmaceutical Ingredients (APIs) Product Type
- 3.4.3 Date of International Manufacturers Enter into High Potency Active Pharmaceutical Ingredients (APIs) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Product
- 4.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Product
- 4.3 High Potency Active Pharmaceutical Ingredients (APIs) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Breakdown Data by End User
6 North America
- 6.1 North America High Potency Active Pharmaceutical Ingredients (APIs) by Countries
- 6.1.1 North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Countries
- 6.1.2 North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America High Potency Active Pharmaceutical Ingredients (APIs) by Product
- 6.3 North America High Potency Active Pharmaceutical Ingredients (APIs) by End User
7 Europe
- 7.1 Europe High Potency Active Pharmaceutical Ingredients (APIs) by Countries
- 7.1.1 Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Countries
- 7.1.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) by Product
- 7.3 Europe High Potency Active Pharmaceutical Ingredients (APIs) by End User
8 Asia Pacific
- 8.1 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) by Countries
- 8.1.1 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Countries
- 8.1.2 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) by Product
- 8.3 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) by End User
9 Central & South America
- 9.1 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) by Countries
- 9.1.1 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Countries
- 9.1.2 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) by Product
- 9.3 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) by Countries
- 10.1.1 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Countries
- 10.1.2 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) by Product
- 10.3 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) by End User
11 Company Profiles
- 11.1 Lonza
- 11.1.1 Lonza Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.1.5 Lonza Recent Development
- 11.2 Novartis International AG
- 11.2.1 Novartis International AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.2.5 Novartis International AG Recent Development
- 11.3 BASF AG
- 11.3.1 BASF AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.3.5 BASF AG Recent Development
- 11.4 Carbogen Amcis AG
- 11.4.1 Carbogen Amcis AG Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.4.5 Carbogen Amcis AG Recent Development
- 11.5 Eli Lilly and Company
- 11.5.1 Eli Lilly and Company Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.5.5 Eli Lilly and Company Recent Development
- 11.6 Teva Pharmaceutical Industries Ltd
- 11.6.1 Teva Pharmaceutical Industries Ltd Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.6.5 Teva Pharmaceutical Industries Ltd Recent Development
- 11.7 Bristol-Myers Squibb
- 11.7.1 Bristol-Myers Squibb Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.7.5 Bristol-Myers Squibb Recent Development
- 11.8 Pfizer Inc.
- 11.8.1 Pfizer Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.8.5 Pfizer Inc. Recent Development
- 11.9 Roche Diagnostics.
- 11.9.1 Roche Diagnostics. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.9.5 Roche Diagnostics. Recent Development
- 11.10 Hospira Inc
- 11.10.1 Hospira Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Products Offered
- 11.10.5 Hospira Inc Recent Development
- 11.11 Boehringer Ingelheim
- 11.12 Covidien Plc
- 11.13 Merck & Co
- 11.14 Bayer AG
- 11.15 Sigma-Aldrich Corporation
- 11.16 Sanofi Aventis.
12 Future Forecast
- 12.1 High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast by Regions
- 12.1.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Forecast by Regions 2019-2025
- 12.1.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Forecast by Regions 2019-2025
- 12.2 High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast by Product
- 12.2.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Forecast by Product 2019-2025
- 12.2.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Forecast by Product 2019-2025
- 12.3 High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast by End User
- 12.4 North America High Potency Active Pharmaceutical Ingredients (APIs) Forecast
- 12.5 Europe High Potency Active Pharmaceutical Ingredients (APIs) Forecast
- 12.6 Asia Pacific High Potency Active Pharmaceutical Ingredients (APIs) Forecast
- 12.7 Central & South America High Potency Active Pharmaceutical Ingredients (APIs) Forecast
- 12.8 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 High Potency Active Pharmaceutical Ingredients (APIs) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on High Potency Active Pharmaceutical Ingredients (APIs) . Industry analysis & Market Report on High Potency Active Pharmaceutical Ingredients (APIs) is a syndicated market report, published as Global High Potency Active Pharmaceutical Ingredients (APIs) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of High Potency Active Pharmaceutical Ingredients (APIs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
